FI955306A0 - Plasmaproteiinien puhdistus - Google Patents

Plasmaproteiinien puhdistus

Info

Publication number
FI955306A0
FI955306A0 FI955306A FI955306A FI955306A0 FI 955306 A0 FI955306 A0 FI 955306A0 FI 955306 A FI955306 A FI 955306A FI 955306 A FI955306 A FI 955306A FI 955306 A0 FI955306 A0 FI 955306A0
Authority
FI
Finland
Prior art keywords
pct
plasma protein
aqueous phase
detergent
sec
Prior art date
Application number
FI955306A
Other languages
English (en)
Swedish (sv)
Other versions
FI955306A (fi
FI113779B (fi
Inventor
Sven Isaksson
Stefan Winge
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI955306A publication Critical patent/FI955306A/fi
Publication of FI955306A0 publication Critical patent/FI955306A0/fi
Application granted granted Critical
Publication of FI113779B publication Critical patent/FI113779B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
FI955306A 1993-05-07 1995-11-06 Plasmaproteiinien puhdistus FI113779B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9301582 1993-05-07
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins
SE9400422 1994-05-06
PCT/SE1994/000422 WO1994026287A1 (en) 1993-05-07 1994-05-06 Purification of plasma proteins

Publications (3)

Publication Number Publication Date
FI955306A FI955306A (fi) 1995-11-06
FI955306A0 true FI955306A0 (fi) 1995-11-06
FI113779B FI113779B (fi) 2004-06-15

Family

ID=20389869

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955306A FI113779B (fi) 1993-05-07 1995-11-06 Plasmaproteiinien puhdistus

Country Status (15)

Country Link
US (1) US5817765A (fi)
EP (1) EP0700300B1 (fi)
JP (1) JP3771935B2 (fi)
AT (1) ATE205719T1 (fi)
AU (1) AU677332B2 (fi)
CA (1) CA2161804C (fi)
DE (1) DE69428356T2 (fi)
DK (1) DK0700300T3 (fi)
ES (1) ES2164702T3 (fi)
FI (1) FI113779B (fi)
NO (1) NO313084B1 (fi)
NZ (1) NZ266234A (fi)
PT (1) PT700300E (fi)
SE (1) SE9301582D0 (fi)
WO (1) WO1994026287A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
US6518406B1 (en) 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
KR20020063597A (ko) * 1999-12-20 2002-08-03 미츠비시 웰파마 가부시키가이샤 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법
CA2534900A1 (en) * 2003-08-12 2005-02-17 Octapharma Ag Process for preparing an alpha-1-antitrypsin solution
CA2572327A1 (en) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt. Ltd. Process for the preparation of virus-safe biological fluids
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
WO2010033913A1 (en) * 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
CN102812118B (zh) * 2010-04-08 2016-01-20 恰根有限公司 分离和纯化核酸的方法
EP2395082A1 (en) 2010-06-14 2011-12-14 QIAGEN GmbH Extraction of nucleic acids from wax-embedded samples
US8921062B2 (en) 2010-11-09 2014-12-30 Quest Diagnostics Investments Incorporated Diagnostic and prognostic assays based on circulating tyrosine kinase activity
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2014055552A1 (en) * 2012-10-03 2014-04-10 Csl Behring Llc A method of purifying proteins
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"

Also Published As

Publication number Publication date
CA2161804C (en) 2003-12-02
NO313084B1 (no) 2002-08-12
ES2164702T3 (es) 2002-03-01
AU677332B2 (en) 1997-04-17
JP3771935B2 (ja) 2006-05-10
CA2161804A1 (en) 1994-11-24
DE69428356T2 (de) 2002-04-25
SE9301582D0 (sv) 1993-05-07
JPH08509746A (ja) 1996-10-15
FI955306A (fi) 1995-11-06
NO954428L (no) 1995-11-06
ATE205719T1 (de) 2001-10-15
PT700300E (pt) 2002-03-28
NZ266234A (en) 1996-06-25
EP0700300B1 (en) 2001-09-19
FI113779B (fi) 2004-06-15
DE69428356D1 (de) 2001-10-25
WO1994026287A1 (en) 1994-11-24
NO954428D0 (no) 1995-11-06
DK0700300T3 (da) 2001-12-31
US5817765A (en) 1998-10-06
EP0700300A1 (en) 1996-03-13
AU6763494A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
FI955306A0 (fi) Plasmaproteiinien puhdistus
DK0707594T3 (da) Adskillelse af proteiner
NO20031471L (no) Glykoformer av faktor VII
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
PL322163A1 (en) Hydroxyethylaminosulphonamides of bis-amino acids as inhibitors of retroviral protease
DE69512416D1 (de) Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
DE69327971T2 (de) Parfümierte waschmittelpulvern
DE69626976D1 (de) BEHANDLUNG EINER PROTEINLÖSUNG MIT A1/Fe UND ANSCHLIESENDE MEMBRANKONZENTRATION
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
CA2044324A1 (en) Multi-stage infectious waste treatment system
DE69811758D1 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
FI1343809T4 (fi) Menetelmä alfa-1 proteinaasinestäjän valmistamiseksi
ES2174481T3 (es) Empleo de soluciones que contienen enzimas para la limpieza de tanques de fermentacion o de almacenamiento.
ATE309227T1 (de) Substituierte 1,3,5-triazine als herbizide
ATE103606T1 (de) Verfahren zur herstellung von sulfinylpristinamycin iib.
DE60105760D1 (de) Verfahren zur behandlung von mitteln zur reinigung von abgasen
NO943024L (no) Vandige detergentblandinger inneholdende kalsiumioner for harde flater
ATE256655T1 (de) Neue aminsäure-derivate, verfahren zur ihrer herstellung, ihre zusammensetzungen und ihre verwendung als sonnenfilter
TH27497B (th) ผลิตภัณฑ์แชมพูสำหรับปรับสภาพผม
RU95108858A (ru) Способ очистки технической акриловой кислоты

Legal Events

Date Code Title Description
MM Patent lapsed